Hypersensitivity to cyclooxygenase inhibitory drugs in children: A study of 164 cases

European Journal of Dermatology

Volumn 18, Issue 5, 2008, Pages 561-565

  Hassani, Amale ^a   Ponvert, Claude ^b   Karila, Chantal ^b   Le Bourgeois, Muriel ^b   De Blic, Jacques ^b   Scheinmann, Pierre ^b  

^a MILITARY HOSPITAL MOHAMMED V   (Morocco)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Acetylsalicylic acid; Children; Cyclooxygenase inhibitors; Drug hypersensitivity; Ibuprofen; Non steroidal anti inflammatory drugs; Paracetamol

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADOLESCENT; AGE DISTRIBUTION; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; CHILD; CHILD CARE; COUGHING; DISEASE SEVERITY; DRUG CROSS REACTIVITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RESPIRATORY TRACT DISEASE; RHINITIS; RISK ASSESSMENT; RISK FACTOR; SKIN MANIFESTATION; SYMPTOM; URTICARIA;

ACETAMINOPHEN; ADOLESCENT; ASPIRIN; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE INHIBITORS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IBUPROFEN; INFANT; MALE; RISK FACTORS;

EID: 52649130858     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0480     Document Type: Article

References (36)

1. Haddi E, Charpin M, Tafforeau M, Kulling G, Lanteaume A, Kleisbauer JP, et al. Atopy and systemic reactions to drugs. Allergy 1990; 45: 236-9.
2. Rebelo Gomes E, Demoly P. Epidemiology of drug hypersensitivity reactions. Curr Opin Allergy Clin Immunol 2005; 5: 309-16.
3. Hunziker T, Kunzi EP, Braunschweig S, Zehnder D, Hoigné R. Comprehensive drug monitoring (CHDM): adverse skin reactions, a 20-year study. Allergy 1997; 52: 388-93.
4. Johansson SGO, Hourihane JOB, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-24.
5. Botey J, Ibero M, Malet A, Marin A, Eseverri JL. Aspirin-induced recurrent urticaria and recurrent angioedema in non atopic children. Ann Allergy 1984; 53: 265-7.
6. Settipane RA. Aspirin and allergic diseases: a review. Am J Med 1983; 74: 102-9.
7. Bochenek G, Nizankowska E, Szczeklik A. Testing for aspirin hypersensitivity. Allergy 2002; 57: 562-5.
8. Kalyoncu AF, Karakaya G, Sahin AA, Boris YI. Occurrence of allergic conditions in asthmatics with analgesic intolerance. Allergy 1999; 54: 428-35.
9. Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999; 104: e39-e44.
10. Martin-Munoz F, Moreno-Ancillo A, Dominguez-Noce C, Diaz-Pena JM, Garcia Ara C, Boyano T, et al. Evaluation of drug-related hypersensitivity reactions in children. Invest Allergol Clin Immunol 1999; 9: 172-7.
11. Titchen T, Cranswick N, Beggs S. Adverse reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a pediatric hospital. Br J Clin Pharmacol 2005; 59: 718-23.
12. Schubert B, Grosse Perdekamp MT, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality? Eur J Dermatol 2005; 15: 164-7.
13. Kidon MI, Kang LW, Chin CW, Hoon LS, See Y, Goh A, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal anti-inflammatory drugs among young, asion, atopic children. Pediatrics 2005; 16: e675-e680.
14. Asero R. Oral aspirin challenges in patients with a history of intolerance to single nonsteroidal anti-inflammatory drugs. Clin Exp Allergy 2005; 35: 713-6.
15. Kvedariene V, Bencherioua AM, Messaad D, Godard P, Bousquet J, Demoly P. The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blinded trial. Clin Exp Allergy 2002; 32: 1366-9.
16. Gala G, Blanco R, Quirce S, Perez-Camo I, Alvarez-Fernandez JA, Diez-Gomez ML. Diclofenac-induced urticaria with aspirin tolerance. Allergy 1998; 53: 623-4.
17. Gamboa PM, Sanz ML, Caballero MR, Antéparo I, Urrutia I, Jouregui I, et al. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol-allergic patients. Allergy 2003; 58: 312-7.
18. Grob M, Pichler WJ, Wüthrich B. Anaphylaxis to celecoxib. Allergy 2002; 57: 264-5.
19. Mendizabal S, Diez-Gomez ML. Paracetamol sensitivity without aspirin intolerance. Allergy 1998; 53: 457-8.
20. Romano A, Pietrantonio F. Delayed hypersensitivity to flurbiprofen. J Intern Med 1997; 241: 81-3.
21. Zhu DX, Zhao L, Mo L, Li HL. Identification and characterization of IgE reactivities to aspirin and related coumpounds. J Invest Allergol Clin Immunol 1997: 160-8.
22. Boussetta K, Ponvert C, Karila C, Le Bourgeois M, de Blic J, Scheinmann P. Hypersensitivity reactions to paracetamol in children. Allergy 2005; 60: 1174-7.
23. Kidon MI, Kang LW, Chin CW, Hoon LS, Goh A, Poh Lin JT, et al. Hypersensitivity to paracetamol in NSAID-sensitive Asian children. Int Arch Allergy Immunol 2007; 144: 51-6.
24. Sanchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F. Hypersensitivity to nonsteroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol 2004; 15: 376-80.
25. Settipane RA, Stevenson DD. Cross-reactivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1989; 84: 26-33.
26. Levine BB. Immunological mechanisms of penicillin allergy: a haptenic model system for the study of allergic diseases in man. N Engl J Med 1966; 275: 1115-25.
27. Ponvert C, de Blic J, Le Clainche L, Paupe J, Scheinmann P. Allergy to betalactam antibiotics in child. Pediatrics 1999; 104: eA5-e5A.
28. Ponvert C, Karila C, Bakondé VB, de Blic J, Le Bourgeois M, Scheinmann P. Allergy to multivalent vaccines in children: a study of 30 cases using immediate, semi-late and late responses in skin tests, specific antibody determinations, and challenge with monovalent and bivalent vaccines. Rev Fr Allergol Immunol Clin 2001; 41: 701-11.
29. Lebel B, Messaad D, Kvedariene K, Rougier M, Bousquet J, Demoly P. Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001; 56: 688-92.
30. Sanz ML, Gamboa P, de Weck AL. A new combined test with flow cytometric basophil activation and determination of sulfidoleukotrienes is usefu or in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005; 136: 58-72.
31. Nizankowska-Mogilnicka E, Bochenek G, Mastarlerz L, Swierzynska M, Picado C, Scadding G, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62: 1111-8.
32. Ispano M, Fontana A, Scibilia J, Ortolani C. Oral challenge with alternative nonsteroidal anti-inflammatory drugs and paracetamol in patients intolerant to these agents. Drugs 1993; 46: 253-6.
33. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and non-ionic contrast media: a report from the Japanese Committee on the safety of contrast media. Radiology 1990; 175: 621-8.
34. Adkinson NF, Drug allergy. In: Adkinson Jr. NF, Yunginger JW, Busse WW, et al., eds. Middlen's allergy: principles and practice, 6th edn. Philadelphia, USA: Mosby, 2003: 1679-94.
35. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 413-21.
36. Kato M, Nishida S, Kitasato H, Sakata N, Kawai S. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of nonsteroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol 2001; 53: 1679-85.